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ABSTRACT
Tegument is the unique structure of a herpesvirion
which occupies the space between nucleocapsid and
envelope. Accumulating data have indicated that inter-
actions among tegument proteins play a key role in
virion morphogenesis. Morphogenesis of gam-
maherpesviruses including Kaposi’s sarcoma-associ-
ated herpesvirus (KSHV) and Epstein-Barr virus (EBV) is
poorly understood due to the lack of efﬁcient de novo
lytic replication in cell culture. Murine gammaherpesvi-
rus-68 (MHV-68) is genetically related to these two
human herpesviruses and serves as an effective model
to study the lytic replication of gammaherpesviruses.
We previously showed that ORF33 of MHV-68 encodes a
tegument protein and plays an essential role in virion
maturation in the cytoplasm. However, the molecular
mechanism of how ORF33 participates in virion mor-
phogenesis has not been elucidated. In this study we
demonstrated that ORF38 of MHV-68 is also a tegument
protein and is localized to cytoplasmic compartments
during both transient transfection and viral infection.
Immuno-gold labeling assay showed that ORF38 is only
present on virions that have entered the cytoplasmic
vesicles, indicating that ORF38 is packaged into virions
during secondary envelopment. We further showed that
ORF38 co-localizes with ORF33 during viral infection;
therefore, the interaction between ORF38 and ORF33 is
conserved among herpesviruses. Notably, we found that
although ORF33 by itself is distributed in both the
nucleus and the cytoplasm, in the presence of ORF38,
ORF33 is co-localized to trans-Golgi network (TGN), a
site where secondary envelopment takes place.
KEYWORDS gammaherpesvirus, tegument protein,
ORF38, ORF33, TGN
INTRODUCTION
The herpesviridae is a family of large DNA viruses. Based on
genome structure and biological properties, herpesviruses
are classiﬁed into three subfamilies, Alphaherpesvirinae,
Betaherpesvirinae and Gammaherpesvirinae. Gam-
maherpesviruses are also called tumor-associated herpe-
sviruses. Epstein-Barr virus (EBV) and Kaposi’s sarcoma-
associated herpesvirus (KSHV), two human gam-
maherpesviruses, are causative agents of several malig-
nancies, such as lymphomas, nasopharyngeal carcinoma
and Kaposi’s sarcoma (Soulier et al., 1995; Ganem, 2006;
Kutok and Wang, 2006). Like other herpesviruses, EBV and
KSHV are characterized as having two distinct phases in
their life cycle: lytic replication and latency (Sunil-Chandra
et al., 1992; Decker et al., 1996a, 1996b). Studies have
shown that both lytic replication and latency play important
roles in tumorigenesis (Bais et al., 1998; Martin et al., 1999;
Stine et al., 2000; Blackman and Flano, 2002; Grundhoff and
Ganem, 2004; Stevenson and Efstathiou, 2005).
A signiﬁcant event during lytic replication is the formation of
mature virions which are released into extracellular space to
initiate new infection cycles in neighboring uninfected cells. A
mature herpesvirion consists of a DNA genome, an icosahe-
dral capsid, a thick tegument and an envelope containing lipid
bilayer spiked with viral glycoproteins (Dai et al., 2008). Mor-
phogenesis of a herpesvirion is a complicated multiple-step
process. Brieﬂy, it begins with the auto-assembly of capsid
proteins into a capsid in the nucleus. After encapsidation of
virus genome, a nucleocapsid travels to the inner nuclear
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membranewhere it acquires primary envelope and enters into
the perinuclear space. Nuclear egress or “de-envelopment” is
accomplished by fusion of the primary envelope with the outer
nuclear membrane and release of the nucleocapsid into the
cytoplasm. The nucleocapsid acquires most tegument pro-
teins and envelope proteins in the cytoplasm and completes
its maturation at trans-Golgi network (TGN)-derived vesicles,
a process called “secondary envelopment”. A mature virion is
ﬁnally released into the extracellular space through fusion of
the vesicles with the cellular membrane (Mettenleiter et al.,
2006; Guo et al., 2010).
Until now, studies on morphogenesis of herpesviruses
have mostly focused on alphaherpesviruses such as herpes
simplex virus-1 (HSV-1) and to a less extent on beta-herpe-
sviruses such as human cytomegalovirus (HCMV) (Mette-
nleiter et al., 2009). Little is knownabout themorphogenesis of
gammaherpesviruses due to the lack of efﬁcient lytic replica-
tion of KSHV and EBV in cell culture. Murine gammaherpes-
virus-68 (MHV-68) is genetically related to these two human
herpesviruses and replicates robustly in cell culture, pre-
senting an effective model to study the de novo infection
process of gammaherpesviruses (Efstathiou et al., 1990; Si-
mas and Efstathiou, 1998). Using multiple approaches, we
previously showed that MHV-68 ORF33 is a tegument protein
that is essential for virion morphogenesis (Guo et al., 2009).
However, the molecular mechanism of ORF33 involved in
virion morphogenesis remained unclear. ORF33 is a con-
served tegument protein in herpesvirus family. Studies on its
homologues in HSV-1 and HCMV (UL16 and UL94, respec-
tively) showed that they both interact with another conserved
tegument protein, designated as UL11 in HSV-1 and UL99 in
HCMV, and that both interactions are involved in virion matu-
ration in the cytoplasm (Yeh et al., 2008; Phillips et al., 2012).
The homologue of UL11 in MHV-68 is ORF38. A previous
study on genome-wide protein interaction network of MHV-68
has showed that ORF33 interacts with ORF38 (Lee et al.,
2011); however, the role of ORF38 inMHV-68morphogenesis
has not been characterized.
In this study,we ﬁrst demonstrated thatMHV-68ORF38 is a
tegument protein and that it is localized to cytoplasmic com-
partments during both transient transfection and viral infec-
tion. We further showed that ORF38 is packaged into virions
within cytoplasmic vesicles during secondary envelopment. In
addition, we showed co-localization of ORF38 and ORF33
during viral infection. Notably, we found that although ORF33
by itself is distributed in both the nucleus and the cytoplasm, its
interaction with ORF38 makes it localize to TGN, a site where
secondary envelopment takes place.
RESULTS
MHV-68 ORF38 encodes a tegument protein
To facilitate the characterization of MHV-68 ORF38, we ﬁrst
expressed and puriﬁed His-tagged ORF38 in E. coli and
used it to generate a rabbit polyclonal antibody. Lysate from
BHK-21 cells infected with MHV-68 was examined by Wes-
tern blotting analysis to test the speciﬁcity of the antibody. A
12-kDa protein was detected in virus infected BHK cells
(Fig. 1A, lane 1) but not in mock infected cells (Fig. 1A, lane
2). In contrast, no band was detected from either MHV-68-
infected or mock-infected cells by preimmune rabbit serum
(data not shown).
The MHV-68 ORF38 encodes a protein of 75 aa and
shares 27% amino acid sequence identity to its homologue
in EBV (named BBLF1), which was identiﬁed as a compo-
nent of the virion-associated proteins (Johannsen et al.,
2004). The homologues of ORF38 in alpha- and beta-her-
pesvirus family were also reported to be virion-associated
tegument proteins (Kattenhorn et al., 2004; Loret et al.,
2008). Therefore, it is very likely that MHV-68 ORF38 is also
a virion protein; however, a previous mass spectrometric
analysis of puriﬁed MHV-68 virions did not report the iden-
tiﬁcation of ORF38 (Bortz et al., 2003). We therefore decided
to ﬁrst determine whether ORF38 is associated with MHV-68
virions.
Mature MHV-68 virions were harvested from supernatant
of MHV-68-infected cells and puriﬁed through gradient
ultracentrifugation. Virions were lysed, resolved on SDS-
PAGE, and analyzed by Western blotting, using the anti-
ORF38 polyclonal antibody. A 12-kDa protein, consistent
with the molecular weight of ORF38 found in MHV-68-
infected cell lysate (Fig. 1B, lane 2), was detected in virion
lysate (Fig. 1B, lane 1), demonstrating that ORF38 protein is
indeed associated with viral particles. We next performed
trypsin and detergent treatment experiment, a classical
assay to determine the detailed localization of a virion pro-
tein within the viral particles (Bortz et al., 2003), and com-
pared the sensitivity of ORF38 to trypsin and/or detergent
treatment to that of known capsid protein ORF26, tegument
protein ORF33, and envelope protein glycoprotein B (gB). As
expected, gB was sensitive to trypsin in both the presence
and the absence of detergent (Fig. 1C, bottom panel)
whereas capsid protein ORF26 was resistant to trypsin and/
or detergent treatment (Fig. 1C, top panel). Similar to
ORF33, ORF38 was sensitive to trypsin treatment in the
presence of detergent (Fig. 1C, lane 4). However, unlike
ORF33, ORF38 was partially sensitive to detergent in the
absence of trypsin (Fig. 1C, lane 2). As ORF33 has been
identiﬁed as a tegument protein of MHV-68 that is associated
tightly with the capsid (Guo et al., 2009), these data dem-
onstrated that ORF38 is a tegument protein but binds less
strongly to capsid than does ORF33.
MHV-68 ORF38 localizes to trans-Golgi network (TGN)
The fact that ORF38 binds loosely to capsid suggests that
ORF38 may be an outer tegument protein and participate in
the secondary envelopment of viral particles. As the function
of a protein is inevitably linked to its localization within the
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cell, we examined the subcellular localization of ORF38.
Cells were infected with MHV-68 and indirect immunoﬂuo-
rescence assay was performed using the anti-ORF38 anti-
body. As shown in Fig. 2A, ORF38 mainly localized to the
cytoplasm, with a predominant distribution in the juxtanu-
clear space. To further deﬁne the subcellular localization of
ORF38, we investigated the co-localization of ORF38 with a
panel of known protein markers for subcellular compart-
ments. These markers, TGN38 for TGN, EEA1 for early
endosome, LAMP1 for late endosome, and VPS37C for
multivesicular bodies (MVB), respectively, are all fused to
GFP. To facilitate the analysis, we ﬁrst constructed a plasmid
that expresses ORF38 fused to the N-terminus of RFP
(named pDsRed-38). We then conducted co-transfection
experiment with pDsRed-38 and a plasmid encoding one of
the markers. As shown in Fig. 2B, ORF38 displayed partial
co-localization with the TGN marker. Signiﬁcant signal
overlap was also observed between ORF38 and the late
endosome marker. In contrast, minimal co-localization was
observed between ORF38 and the early endosome marker
or the MVB marker. As herpesvirus secondary envelopment
is believed to occur at the TGN (Mettenleiter et al., 2009), the
localization of ORF38 in TGN is consistent with its potential
role in secondary envelopment during virion morphogenesis.
ORF38 is packaged into virions during secondary
envelopment
To determine the role of ORF38 in MHV-68 virion morpho-
genesis, we next performed an immuno-gold labeling assay
to examine at which step of virion morphogenesis ORF38 is
packaged into virions. Cells were infected with MHV-68,
ﬁxed and embedded. Samples were processed and ultrathin
sections were obtained. The sections were immunolabeled
with either the anti-ORF38 rabbit polyclonal antibody or the
rabbit IgG as a negative control, followed by a secondary
antibody conjugated with 5-nm gold particles. In the negative
control sample treated with rabbit IgG, no gold particle was
found on virions (Fig. 3A). In the sample treated with the anti-
ORF38 antibody, viral particles were readily found in the
nucleus, however, no gold particle was detected either on
the viral particles or in other areas of the nucleus (Fig. 3B),
consistent with the cytoplasmic localization of ORF38 as
demonstrated by our immunoﬂuorescence data (Fig. 2A). In
contrast, abundant ORF38 was present around or within
vesicles in the cytoplasm where virions were undergoing
secondary envelopment (Fig. 3C and 3D). Notably, ORF38
was only present on virions that had entered vesicles but not
on virions outside the vesicles (Fig. 3D). These data clearly
indicated that the tegument protein ORF38 is packaged into
virions during secondary envelopment.
ORF38 interacts with ORF33
Tegumentation is an important stage of morphogenesis for a
herpesvirus particle and involves a complex and dynamic
process of protein-protein interactions. We therefore tested
the interaction of ORF38 with other tegument proteins and
found out that ORF38 interacts with ORF33, consistent with
a previous report (Lee et al., 2011). Brieﬂy, coimmunopre-
cipitation (co-IP) experiment was performed with cell lysates
from 293T cells transiently transfected with either a plasmid
expressing HA-tagged ORF33 (HA-33) or a plasmid
expressing 3xFLAG-CBP-tagged ORF38 (TAG-38) or both.
As shown in Fig. 4A, ORF38 interacted with ORF33 in the
absence of other viral proteins. To conﬁrm that the interac-
tion between ORF33 and ORF38 exists in the context of viral
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Figure 1. MHV-68 ORF38 encodes a tegument protein. (A) ORF38 is expressed during MHV-68 lytic infection. BHK cells were
infected with WT MHV-68 at an MOI of 3. At 24 hpi, cells were lysed and subjected to Western blotting analysis with an anti-ORF38
polyclonal antibody or a monoclonal antibody speciﬁc for β-actin. Lysate from mock infected cells was used as a negative control.
(B) ORF38 is a component of mature MHV-68 virions. Mature virions puriﬁed by gradient centrifugation were resolved via SDS-PAGE
and analyzed using the anti-ORF38 polyclonal antibody. Lysate from virus infected BHK cells was used as a positive control.
(C) Sensitivity of ORF38 to detergent and trypsin treatment. The puriﬁed virions were treated with trypsin or detergent or both, as
described in MATERIALS AND METHODS. The resulting tegument-nucleocapsid complexes were subjected to Western blotting
analysis individually using anti-ORF26, anti-ORF33, anti-ORF38 and anti-gB polyclonal antibodies.
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these two proteins during viral infection. Cells were infected
with MHV-68 and indirect immunoﬂuorescence assay was
performed with the anti-ORF38 antibody and an anti-ORF33
antibody we previously prepared. Consistent with our previ-
ous observation (Fig. 2), endogenously expressed ORF38
was localized to the cytoplasm (Fig. 4B, column 2). We
previously showed that ORF33 was distributed in both the
cytoplasm and the nucleus in the absence of other viral
proteins (Guo et al., 2009). Here we observed that, in the
context of viral infection, endogenously expressed ORF33
accumulated more in the nucleus than in the cytoplasm at
18 h or 24 h postinfection (Fig. 4B, column 3). More
interestingly, at these time points, the cytoplasmic portion
of ORF33 proteins co-localized with ORF38 (Fig. 4B,
column 4).
ORF38 and ORF33 co-localize with TGN
The fact that only the cytoplasmic portion of ORF33 co-
localized with ORF38 during viral infection suggested that
other viral factors may interact with ORF33 and affect its
localization. To focus on the role of ORF38, we further
analyzed the interaction of this pair of proteins in the
absence of other viral proteins. Cells were transfected with
pEGFP-33 or pDsRed-38 or both, stained with DAPI and
then observed with a confocal laser microscope. As shown
in Fig. 5A, ORF33 by itself localized to both the nucleus and
the cytoplasm, whereas ORF38 by itself localized to juxta-
nuclear space within the cytoplasm. Notably, in the presence
of ORF38, almost all ORF33 accumulated in the cytoplasmic
areas where ORF38 localized to. Further analysis using
B









Figure 2. Subcellular localization of MHV-68 ORF38. (A) ORF38 localizes to the cytoplasm. Vero cells were infected with WT
MHV-68 at an MOI of 3. At 24 hpi, cells were ﬁxed for indirect immunoﬂuorescence analysis using the anti-ORF38 polyclonal
antibody. (B) Co-localization of ORF38 with different cytoplasmic organelles. Vero cells were cotransfected with pDsRed-38 plus
pTGN-38 GFP or pEEA1-GFP or pLAMP1-GFP or pVPS37C-GFP. At 24 h posttransfection, cells were ﬁxed, stained with DAPI, and
examined with a confocal laser microscope.
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TGN38, the protein marker for TGN, demonstrated that the
cytoplasmic compartment that ORF33 and ORF38 co-local-
ized with is TGN (Fig. 5B).
DISCUSSION
Studies from all herpesvirus subfamilies indicated that tegu-
ment, composed mostly of tegument proteins, plays a crucial
role during virion morphogenesis. Tegumentation is a com-
plicated process that involves multiple protein-protein inter-
actions (Bortz et al., 2007; Guo et al., 2010; Phillips and
Bresnahan, 2012;Wang et al., 2012). However, themolecular
mechanisms responsible for gammaherpesvirus tegumenta-
tion remainedunclear.Herewe report thatMHV-68ORF38 is a
virion protein (Fig. 1B). Furthermore, our trypsin and detergent
sensitivity data indicated that ORF38 is a tegument protein but
binds to capsid less tightly thanORF33does, sinceORF38 fell
off from virions in the presence of detergent only (Fig. 1C).
Therefore ORF38 is very likely a component of the outer teg-
ument and associated with glycoprotein(s) in the virion. This
idea is consistent with its localization at TGN (Figs. 2B and
5B), where most viral glycoproteins are located.
Tegument formation is generally thought to originate
during primary envelopment, with additional tegument pro-
teins being incorporated in the cytoplasm following nuclear
egress and ﬁnally at the TGN-derived vesicles. Different
tegument proteins are added onto virions at different intra-
cellular locations (Kelly et al., 2009). Using the immuno-gold
labeling assay, we previously showed that MHV-68 ORF52,
a tegument protein essential for virion maturation in the
cytoplasm, is present on both immature virions in the cyto-
plasm and on virions that have entered vesicles (Wang et al.,
2012). Unlike ORF52, ORF38 is only present on virions that
have entered the vesicles but not present on immature viri-
ons outside the vesicles (Fig. 3). Abundant ORF38 is also
present on these vesicles where secondary envelopment
takes place. Together, these data indicate that ORF38 is
packaged into virions during secondary envelopment.
ORF38 is conserved in all three herpesvirus subfamilies.
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Figure 3. Immuno-gold labeling of ORF38 in MHV-68 infected cells. BHK cells were infected with WT MHV-68 at an MOI of 5.
Ultrathin sections were immunolabeled with rabbit IgG as a negative control (A) or anti-ORF38 rabbit polyclonal antibody (B–D),
followed by a secondary antibody conjugated with 5-nm gold particles. No gold particle was found in samples treated with rabbit IgG
(A). ORF38 was not detected in the nucleus (Nu) of virus infected cells (B). In the cytoplasm (Cy), ORF38 was found around and
within the vesicles (C and D) as well as on virions within the vesicles (▲) (D) but not found on virions outside the vesicles (▼)(D). Bars:
A, B and C, 100 nm; D, 200 nm.
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UL99, respectively. UL11 and UL99 are virion associated
tegument proteins. Both are myristoylated and accumulate
on the cytoplasmic faces of TGN membrane, a site where
secondary envelopment occurs to produce infectious virus
particles (Sanchez et al., 2000; Loomis et al., 2001). UL11-
null mutant of HSV-1 produced less viral particles and non-
enveloped nucleocapsids accumulated in the cytoplasm,
providing direct evidence that UL11 is involved in the sec-
ondary envelopment of virus (Baines and Roizman, 1992). In
HCMV, UL99-null mutation also resulted in the accumulation
of non-enveloped viral particles in the cytoplasm (Sanchez
et al., 2000). More recent data indicated that the interaction
between UL99 and UL94 is essential for virion morphogen-
esis of HCMV in the cytoplasm (Phillips et al., 2012). The
ORF38 homologue in EBV, BBLF1, has been identiﬁed as a
virion associated protein (Johannsen et al., 2004) and pro-
posed to be involved in virion maturation (Chiu et al., 2012).
However, the detailed molecular mechanism of ORF38
involved in virion morphogenesis of gammaherpesviruses
has remained unclear. Through co-IP and co-localization
studies, we showed in this study that ORF38 interacts with
ORF33 in MHV-68 not only during transient transfection but
also during viral infection. Therefore, the interaction between
ORF38 and ORF33 is a conserved event among
herpesviruses.
Virion assembly is thought to be driven by multiple pro-
tein-protein interactions (Uetz et al., 2006; Rozen et al.,
2008; Mettenleiter et al., 2009). After escape from the
nucleus, partially tegumented capsids arrive at TGN for
secondary envelopment, depending on a number of protein-
protein interactions. The interaction between ORF33 and
ORF38 is most likely among these interactions for MHV-68.
Our previous study using an ORF33-null mutant of MHV-68
showed that ORF33 is not only essential for the cytoplasmic
stage of virion maturation but also plays an important role in
























Figure 4. ORF38 interacts with ORF33. (A) ORF38 interacts with ORF33 in transiently transfected cells. 293T cells were
transfected with pHA-33 or pTAG-38 or both, and at 48 h posttransfection, whole cell lysates (WCL) were prepared, and the
expression of HA-tagged ORF33 and FLAG-tagged ORF38 was examined by Western blotting. The whole cell lysates were further
subjected to immunoprecipitation with anti-Flag M2 agarose and analyzed by Western blotting using an anti-HA or an anti-FLAG
antibody. (B) Co-localization of ORF38 and ORF33 during virus infection. Vero cells were infected with WT MHV-68 at an MOI of 3. At
24 hpi, cells were ﬁxed for indirect immunoﬂuorescence analysis using an anti-ORF33 antibody and the anti-ORF38 antibody
simultaneously.
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Consistently, ORF33 localized to both the nucleus and the
cytoplasm during MHV-68 infection (Fig. 4B). Interestingly, in
the absence of other viral proteins, ORF33 and ORF38
together mostly localized to TGN (Fig. 5). These observa-
tions indicated that interaction of ORF33 with other virion
protein(s) may affect its localization during viral infection.
Because ORF33 is likely an inner tegument protein (Guo
et al., 2009) and ORF38 likely an outer tegument protein
(Fig. 1C), we propose that ORF33 may ﬁrst bind to capsids
within the nucleus and through its interaction with ORF38
may assist with the trafﬁcking of nucleocapsids to TGN for




BHK-21 cells, Vero cells, HeLa cells and 293T cells were cultured in
complete Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum. Wide-type (WT) MHV-68 was
propagatedby infectingBHK-21 cells at amultiplicity of infection (MOI)
of 0.03. To infect BHK-21 cells or Vero cells, the viral inoculum in
DMEM was incubated with cells for 1 h with occasional swirling. The
inoculumwas then removed and replaced with fresh DMEMplus 10%
fetal bovine serum. The titer of virus wasmeasured by a plaque assay
in BHK-21 cells as previously described (Wu et al., 2000).
Plasmids construction
TheORF38expressionplasmidwith 3xFLAG-CBPepitope, pTAG-38,
is a gift from Dr. Ren Sun (University of California, Los Angeles).
pTGN38-GFP, pEEA1-GFP, pLAMP1-GFP and pVPS37C-GFP were
kindly provided by Dr. Tao Xu (Institute of Biophysics, Chinese
Academy of Sciences). Plasmids pHA-33 and pEGFP-33 were con-
structed in the lab as described previously (Guo et al., 2009). The full-
lengthMHV-68ORF38sequencewas cloned into pET-30b (Novagen)
via theEcoRI andXhoI sites to construct pET-30b-38 for expression of
His-tagged ORF38 in E. coli strain Rosetta (DE3). pDsRed-38 was
constructed by inserting the full length ORF38 coding sequences into
theNhe I andXho I sites of pDsRed2. The sequences of primers used
for plasmid construction are available upon request.
Antibodies, immunoprecipitation and immunoblotting
Puriﬁed His-ORF38 of MHV-68 was provided to Experimental Ani-
mal Center, Institute of Genetics and Developmental Biology, Chi-
nese Academy of Sciences to generate polyclonal antibodies
against ORF38. Polyclonal antibodies for ORF26 and gB were kind





B CFP-33 DsRed-38 TGN Merge
Figure 5. ORF38 and ORF33 co-localize with TGN. (A) Translocation of ORF33 into cytoplasm in transiently transfected cells in the
presence of ORF38. HeLa cells were transfected with pEGFP-33 or pDsRed-38 or both. At 24 h posttransfection, cells were stained
with DAPI and then observed with a confocal laser microscope. (B) ORF33 and ORF38 co-localize with TGN. 293T cells were co-
transfected with pCFP-33, pDsRed-38 and pTGN38-GFP. At 24 h posttransfection, cells were ﬁxed, stained with DAPI, and observed
under a confocal laser microscope.
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gifts from Dr. Ren Sun (University of California, Los Angeles).
Polyclonal antibody against ORF33 was described previously (Guo
et al., 2009). Mouse monoclonal antibody against the FLAG epitope
and the HA epitope were purchased from Sigma. 293T cells seeded
onto a 6-cm plate were transfected with 7.5 μg of total DNA by
Lipofectamine-2000 (Invitrogen). Forty-eight hours after transfection,
cells were washed once with ice-cold phosphate-buffered saline
(PBS) and then solubilized in lysis buffer (50 mmol/L Tris-Cl [pH 7.4],
150 mmol/L NaCl, 1% TritonX-100, 1 mmol/L EDTA) with a cocktail
of protease inhibitors. Lysates were cleared by centrifugation for
15 min, 13,000 rpm. Ten percent of the supernatant was used as an
input control. Soluble proteins were mixed with 20 μL of anti-FLAG
M2 agarose (Sigma) and rotated at 4°C for 4 h. Beads were washed
three times with lysis buffer prior to use. Immune complexes were
washed ﬁve times with lysis buffer and supernatant was depleted.
Bound proteins were then subjected to immunoblotting analysis. For
immunoblotting, samples were heated to 100°C and subjected to
SDS-PAGE. Proteins on gels were transferred onto a polyvinylidene
diﬂuoride membrane (Millipore) and incubated sequentially with
appropriate primary antibody and secondary antibody (anti-rabbit or
anti-mouse immunoglobulin G conjugated with horseradish peroxi-
dase), and the proteins were detected by the Enhanced Chemilu-
minescence system (Millipore).
Detergent and trypsin treatment assay
MHV-68 virions were puriﬁed from the supernatant of MHV-68-
infected BHK-21 cells by discontinuous sucrose density gradient
ultracentrifugation as described previously (Bortz et al., 2003).
Brieﬂy, supernatants were cleared of large debris twice by centri-
fugation at 4°C and 1000 g for 15 min. Extracellular viruses were
pelleted by ultracentrifugation through a 7.5% sucrose cushion in a
P28S rotor (Hitachi, 4°C, 65,000 g, 1 h), resuspended in TN buffer
(20 mmol/L Tris [pH 7.8], 50 mmol/L NaCl), and puriﬁed by 10% to
45% discontinuous sucrose density gradient ultracentrifugation in a
P40T rotor (Hitachi, 4°C, 25,000 g, 4.5 h) with slow acceleration
and braking. Visible bands between 25%–35% starting sucrose
positions was saved. Virions were pelleted by ultracentrifugation in
a P40T rotor (Hitachi) at 4°C and 65,000 g for 1 h and resus-
pended in 200 μL of TN buffer. For trypsin and detergent treatment,
20 μL of virion stock was diluted into 200 μL of trypsin buffer (50
mmol/L Tris-HCl [pH 7.5], 150 mmol/L NaCl, 1 mmol/L CaCl2) with
or without 1% Triton X-100 supplementation, followed by addition
of trypsin to a ﬁnal concentration of 4 μg/mL. After incubation at
37°C for 1 h, the reaction was stopped by adding 0.5 mmol/L
phenylmethylsulfonyl ﬂuoride and protease inhibitors, and viral
particles were collected by centrifugation at 20,000 g for 30 min at
4°C.
Indirect immunoﬂuorescence assay (IFA)
Vero cells were infected with MHV-68 at an MOI of 3. At 18 h or 24 h
postinfection, cells were ﬁxedwith 4%paraformaldehyde. The ﬁxed cells
were permeabilized with phosphate-buffered saline (PBS) plus 0.2%
TritonX-100andprocessed for immunoﬂuorescencestaining,whichwas
performedusingaprimaryantibodyagainstORF38orORF33. Following
incubationwithﬂuorescently labeled secondary antibodies, imageswere
captured with a confocal microscope (Olympus).
Immunogold TEM
BHK cells were seeded a day before infection with MHV-68 at 50%
conﬂuence in 10-cm plates. The cells were infected at an MOI of 5.
Sample preparation and immunostaining were performed as descri-
bed previously, with somemodiﬁcations (Wang et al., 2012). Brieﬂy, at
11hafter infection, thecellswereﬁxedwith2%paraformaldehydeplus
0.05% glutaraldehyde in 0.1 mol/L phosphate-buffered saline (PBS)
(pH 7.2) for 15min at 4°C on the plate and embedded in 10%gelatin in
0.1 mol/L PBS. Small blocks were inﬁltrated in 2.3 mol/L sucrose plus
20% polyvinylpolypyrrolidone (PVP) in PBS overnight at 4°C and
quickly plunged into liquid nitrogen. Sections approximately 60-nm
thick were cut with a Leica UC6/FC6 ultramicrotome and picked up
with a wire loop ﬁlled with 2.3 mol/L sucrose. Immunostaining was
performed as follows: the sections were washed in BSA buffer (1%
BSA and 0.15% glycine in PBS) followed by blocking for 30 min using
normal goat serum (1:20 dilution in BSA buffer). Subsequently, the
sections were incubated for 1 h at room temperature with the anti-
ORF38 polyclonal antibody (or rabbit IgG as a negative control) and
then for 1 h at room temperature with goat anti-rabbit IgG conjugated
with 5-nm colloidal gold particles (Sigma). After a brief wash in BSA
buffer and PBS, the sections were treated with 2.5% glutaraldehyde
for 5 min. Finally, the sections were stained by 2% neutral uranyl
acetate sealed with methyl cellulose and examined with a 120-KV
electron microscope (Tecnai; FEI).
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